Skip to main content

Search This Blog

Smart Cancer Guide

Precision and Personalized Oncology: Evidence, Analysis and Genomics

Home
Directory
Cancer Academy & Protocols Library
Virtual Doctor
About Us
Contact Us
Privacy Policy

Posts

Showing posts with the label repurposed drugs

October 04, 2026

dMMR/MSI-H Immunotherapy vs Ivermectin, Fenbendazole, and Mebendazole in Colorectal Cancer: A 2026 Evidence-Graded Comparison

Get link
Facebook
X
Pinterest
Email
Other Apps

September 18, 2026

30 Repurposed and Alternative Cancer Interventions: Evidence-Ranked Analysis (2026 Clinical Update)

Get link
Facebook
X
Pinterest
Email
Other Apps

Older Posts Home

Powered by Blogger

Copyright © 2026 · SmartCancer.org · All Rights Reserved

Archive

October 202615
September 202618
August 202614
July 20263
June 20263
May 20265
April 20266
March 20267
February 20267
January 20264

September 20251
August 20251
June 20251
August 20225
July 202215
June 20221

Show more Show less

Labels

CAR-T3
EGFR inhibitor1
GLP-11
KRAS1
Keytruda3
NCCN1
antibody drug conjugate1
biomarkers10
breakthrough3
breast cancer2

cancer centre1
cancer resistance2
cancer vaccine1
chemotherapy4
colorectal cancer4
combination therapies2
ctDNA1
diet12
genomics6
immunotherapy23
ivermectin6
keto diet2
lung cancer2
mebendazole5
medical specialists1
metabolic therapy10
metronomic chemotherapy1
omega 31
pancreatic cancer7
pembrolizumab1
pharma8
precision oncology18
prevention4
prostate cancer3
repurposed drugs19
stage 43
vitamin and mineral10

Show more Show less

Report Abuse